
FSRH CEU Statement: Response to Study: Intrauterine Contraception Use and Cervical Cancer Risk (January 2018)
File size 139KB | Date: 01 January 2018
Date: 18 Jan 2018
Type: FSRH Clinical Guidance and Clinical Statements
This statement responds to a recent study that reported that women who had used intrauterine contraception (IUC) were over one third less likely to experience invasive cervical cancer than women who had not used IUC. The study has received media attention and the FSRH CEU considered it important to put the findings into perspective.
Key findings
These data come from time periods and settings without HPV vaccination and with variable cervical screening and cervical cancer burden. Therefore, even if there is a protective effect, it is unknown whether this finding would be applicable in the UK setting where HPV vaccination and cervical screening are standard. Further evidence, and consideration of the mechanism by which IUC use could protect against cervical cancer, are needed before conclusions are drawn about this potential non-contraceptive benefit of IUC.
Implications for clinical practice
Read the statement in full at the link below.